From: Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma
Variable | Multivariate | ||
---|---|---|---|
 | Hazard rate | 95%CI* | P |
Gender(male/female) | 0.514 | 0.20-1.32 | 0.1666 |
Age | 1.011 | 0.973-1.050 | 0.586 |
Lymph node metastasis -/+ | 2.257 | 1.136-4.464 | 0.02 |
NMDAR2B methylation -/+ | 0.381 | 0.188-0.775 | 0.0077 |
Gender(male/female) | 0.474 | 0.183-1.228 | 0.1241 |
Age | 1.012 | 0.975-1.051 | 0.5196 |
Stage I, II/III, IV | 2.096 | 0.971-4.525 | 0.0596 |
NMDAR2B methylation -/+ | 0.336 | 0.165-0.684 | 0.0026 |